Fibrinogen is a hematological drug used to treat bleeding disorders. It is a glycoprotein found in the blood that helps form a clot when a person is bleeding. Fibrinogen is produced in the liver and is essential for normal blood clotting. When a person has a deficiency of fibrinogen, they may experience excessive bleeding. Fibrinogen replacement therapy is used to treat this condition. Fibrinogen replacement therapy is used to treat a variety of conditions, including congenital fibrinogen deficiency, acquired fibrinogen deficiency, and bleeding disorders. It is also used to treat bleeding associated with surgery, trauma, and childbirth. The fibrinogen market is highly competitive, with several companies offering products for the treatment of bleeding disorders. Some of the major players in the market include CSL Behring, Grifols, Octapharma, Kedrion, and Shire. These companies offer a range of products, including fibrinogen concentrates, fibrinogen replacement therapies, and fibrinogen-based products. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
